144 related articles for article (PubMed ID: 34898169)
1. Bioinformatic Searching for Optimal RNA Targets of Dimeric Compounds Informs Design of a MicroRNA-27a Inhibitor.
Benhamou RI; Choudhary S; Lekah E; Tong Y; Disney MD
ACS Chem Biol; 2022 Jan; 17(1):5-10. PubMed ID: 34898169
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells.
Feng SY; Dong CG; Wu WK; Wang XJ; Qiao J; Shao JF
Mol Med Rep; 2012 Aug; 6(2):275-81. PubMed ID: 22614734
[TBL] [Abstract][Full Text] [Related]
3. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells].
Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448
[TBL] [Abstract][Full Text] [Related]
4. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
[TBL] [Abstract][Full Text] [Related]
5. Design of a small molecule against an oncogenic noncoding RNA.
Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
[TBL] [Abstract][Full Text] [Related]
6. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
7. Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.
Li Y; Disney MD
ACS Chem Biol; 2018 Nov; 13(11):3065-3071. PubMed ID: 30375843
[TBL] [Abstract][Full Text] [Related]
8. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
[TBL] [Abstract][Full Text] [Related]
9. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.
Xia J; Cheng L; Mei C; Ma J; Shi Y; Zeng F; Wang Z; Wang Z
Curr Pharm Des; 2014; 20(33):5348-53. PubMed ID: 24479798
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
11. miR-27 and miR-124 target AR coregulators in prostate cancer: Bioinformatics and in vitro analysis.
Jafari Najaf Abadi MH; Khorashadizadeh M; Zarei Jaliani H; Jamialahmadi K; Aghaee-Bakhtiari SH
Andrologia; 2022 Oct; 54(9):e14497. PubMed ID: 35700742
[TBL] [Abstract][Full Text] [Related]
12. A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
Costales MG; Hoch DG; Abegg D; Childs-Disney JL; Velagapudi SP; Adibekian A; Disney MD
J Am Chem Soc; 2019 Feb; 141(7):2960-2974. PubMed ID: 30726072
[TBL] [Abstract][Full Text] [Related]
13. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells.
Colangelo T; Polcaro G; Ziccardi P; Muccillo L; Galgani M; Pucci B; Milone MR; Budillon A; Santopaolo M; Mazzoccoli G; Matarese G; Sabatino L; Colantuoni V
Cell Death Dis; 2016 Feb; 7(2):e2108. PubMed ID: 26913599
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5.
Si L; Jia Y; Lin R; Jian W; Yu Q; Yang S
Arch Biochem Biophys; 2019 Jun; 668():9-15. PubMed ID: 31047870
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
16. DNA-encoded library versus RNA-encoded library selection enables design of an oncogenic noncoding RNA inhibitor.
Benhamou RI; Suresh BM; Tong Y; Cochrane WG; Cavett V; Vezina-Dawod S; Abegg D; Childs-Disney JL; Adibekian A; Paegel BM; Disney MD
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35110406
[TBL] [Abstract][Full Text] [Related]
17. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
Guttilla IK; White BA
J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
19. A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.
Suresh BM; Li W; Zhang P; Wang KW; Yildirim I; Parker CG; Disney MD
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33197-33203. PubMed ID: 33318191
[TBL] [Abstract][Full Text] [Related]
20. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
